54
fsa medication
Worth a lookShows low returns (0.1%), but soft demand (-40.1% this quarter) keeps it on the watch list.
Returns
Incredible0.1%return rate — above 5% kills the launch gate
Conversion
Great10.4%search→purchase rate — share of searches ending in a sale
Competition
Great31%top-5 click share — an open shelf
Brand share
Great53%top-5 brand share — no brand owns this niche
Price range
Good$3.66–$41.59cheapest to priciest tracked listing — scored on the share inside $15–$100
Avg price
Good$14.17avg listing price — sweet spot $15–$100
Market size
Okay$103K$103K/yr · 70K searches
Review moat
Bad19,359.38avg incumbent reviews — the moat a new listing must climb
Quality gap
Bad4.8★avg incumbent rating — lower means beatable quality
Growth
Bad-40.1%90-day search growth — must beat 0% to launch
Signals No Dominant Brand